The addition of glucagon receptor agonism is hypothesised to increase energy expenditure and promote hepatic fat breakdown, potentially contributing to additional metabolic benefits
Similar to other GLP-1 medications, retatrutide is an injectable medication that targets hormone receptors in your body that directly impact metabolism and appetite
Prescriptions are written by licensed providers through Arora Health, an independent 50-state medical service organization
Semaglutide GLP-1 is approved for individuals who meet specific criteria, including: If their body mass index (BMI) is 30 or greater
The Alliance for Pharmacy Compounding also provides resources and information for compounding pharmacies, including warnings about the dangers of using semaglutide sodium
Many individuals pursuing GLP-1 drugs personal injury lawsuits express similar sentiments, forming the basis of failure-to-warn claims